You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lymphoma, T-Cell, Cutaneous

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Persistent or Recurrent Cutaneous T-Cell Lymphoma Trial in Australia, Puerto Rico, United States (E7777 9 mcg/kg)

Completed
  • Persistent or Recurrent Cutaneous T-Cell Lymphoma
  • E7777 9 mcg/kg
  • Birmingham, Alabama
  • +21 more
Dec 5, 2022

Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous, Sézary Syndrome Trial in United States (Naloxone Hydrochloride Lotion, 0.5%,

Terminated
  • Mycosis Fungoides
  • +2 more
  • Naloxone Hydrochloride Lotion, 0.5%
  • Placebo Lotion
  • Little Rock, Arkansas
  • +15 more
Oct 26, 2022

Cutaneous T-cell Lymphoma, T-Prolymphocytic Leukemia, T-Large Granulocytic Leukemia Trial in Columbus (Romidepsin, Busulfan,

Recruiting
  • Cutaneous T-cell Lymphoma
  • +4 more
  • Columbus, Ohio
    The Ohio State University Cancer Center
Apr 18, 2022

Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)

Active, not recruiting
  • Relapsed or Refractory Peripheral T-cell Lymphoma(PTCL),Cutaneous T-cell Lymphoma(CTCL),Adult T-cell Leukemia/Lymphoma(ATLL)
  • Yamagata, Japan
    Yamagata University Hospital
Feb 21, 2022

T-Cell Lymphoma Relapsed, Adult T-Cell Leukemia (ATL), Peripheral T-Cell Lymphoma (PTCL) Trial run by the NCI (IL-15 plus,

Completed
Has Results
  • T-Cell Lymphoma Relapsed
  • +4 more
  • IL-15 plus
  • alemtuzumab
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 27, 2022

Non-melanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Trial in Zurich (Talimogene Laherparepvec (T-VEC))

Completed
  • Non-melanoma Skin Cancer
  • +4 more
  • Talimogene Laherparepvec (T-VEC)
  • Zurich, Switzerland
    Department of Dermatology, University Hospital Zurich
Mar 17, 2022

Mycosis Fungoides, Primary Cutaneous T-Cell Non-Hodgkin Lymphoma, Sezary Syndrome Trial in Atlanta (procedure, biological,

Recruiting
  • Mycosis Fungoides
  • +2 more
  • Extracorporeal Photopheresis
  • +2 more
  • Atlanta, Georgia
    Emory University Hospital
Jun 15, 2022

Mycosis Fungoides, Cutaneous T Cell Lymphoma Trial (Low-dose total-skin electron-beam therapy, Phototherapy)

Not yet recruiting
  • Mycosis Fungoides
  • Cutaneous T Cell Lymphoma
  • Low-dose total-skin electron-beam therapy
  • Phototherapy
  • (no location specified)
Jan 24, 2022

Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With

Active, not recruiting
  • Cutaneous T Cell Lymphoma
  • Graft Versus Host Disease
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Aug 31, 2021

    LGLL - Large Granular Lymphocytic Leukemia, Primary Cutaneous T-Cell Lymphoma - Category, Primary Cutaneous CD8-Positive

    Recruiting
    • LGLL - Large Granular Lymphocytic Leukemia
    • +13 more
    • Duarte, California
    • +9 more
    Aug 9, 2022

    Recurrent Anaplastic Large Cell Lymphoma, Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Primary Cutaneous

    Recruiting
    • Recurrent Anaplastic Large Cell Lymphoma
    • +8 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Apr 6, 2022

    BCC - Basal Cell Carcinoma, SCC - Squamous Cell Carcinoma, Merkel Cell Carcinoma Trial in Marseille (L19IL2/L19TNF)

    Not yet recruiting
    • BCC - Basal Cell Carcinoma
    • +6 more
    • Marseille, France
      Hôpital de la Timone
    Jun 22, 2022

    Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

    Active, not recruiting
    • Adult Lymphocyte Depletion Hodgkin Lymphoma
    • +16 more
    • 6,8-bis(benzylthio)octanoic acid
    • bendamustine hydrochloride
    • Winston-Salem, North Carolina
    • +1 more
    Apr 8, 2022

    T-Cell Non-Hodgkin Lymphoma, Acute Myeloid Leukemia, Angioimmunoblastic T-cell Lymphoma Trial in Saint Louis (WU-CART-007)

    Not yet recruiting
    • T-Cell Non-Hodgkin Lymphoma
    • +14 more
    • WU-CART-007
    • Saint Louis, Missouri
      Washington University School of Medicine
    Jan 17, 2023

    Cutaneous T-Cell Lymphoma, Relapsed, Cutaneous T-Cell Lymphoma Refractory Trial in Worldwide (Mogamulizumab)

    Recruiting
    • Cutaneous T-Cell Lymphoma, Relapsed
    • Cutaneous T-Cell Lymphoma Refractory
    • Duarte, California
    • +17 more
    Jul 19, 2022

    CTCL Trial in New Haven (ABT-199 (venetoclax))

    Completed
    • CTCL
    • ABT-199 (venetoclax)
    • New Haven, Connecticut
      Yale New Haven Hospital / Smilow Cancer Center
    Jun 22, 2021

    T-cell Lymphoma Trial (CHOP + CD4, CHOP)

    Terminated
    Has Results
    • T-cell Lymphoma
    • (no location specified)
    May 2, 2022

    Peripheral T Cell Lymphoma, PTCL, Extranodal NK/T-cell Lymphoma Trial in Worldwide (Tislelizumab)

    Completed
    Has Results
    • Peripheral T Cell Lymphoma
    • +18 more
    • Vancouver, British Columbia, Canada
    • +29 more
    Apr 29, 2022

    Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides/Sezary Syndrome Trial in Zürich (Methoxsalen, THERAKOS CELLEX Photopheresis

    Withdrawn
    • Lymphoma, T-Cell, Cutaneous
    • Mycosis Fungoides/Sezary Syndrome
    • Zürich, Switzerland
      UniversitaetsSpital Zurich - Division of Dermatology
    Aug 31, 2021

    Cutaneous T Cell Lymphoma, Mycosis Fungoides, Sezary Syndrome Trial in Leeds ([14C]-resminostat)

    Completed
    • Cutaneous T Cell Lymphoma
    • +2 more
    • Leeds, United Kingdom
      Covance Clinical research Unit Ltd.
    Feb 3, 2022

    Cutaneous T-Cell Lymphoma Trial in United States (SGX301 (synthetic hypericin), Placebo)

    Completed
    Has Results
    • Cutaneous T-Cell Lymphoma
    • SGX301 (synthetic hypericin)
    • Placebo
    • Birmingham, Alabama
    • +32 more
    Mar 22, 2022

    Aggressive Non-Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-Cell Lymphoma Trial in United States

    Active, not recruiting
    • Aggressive Non-Hodgkin Lymphoma
    • +14 more
    • Cholecalciferol
    • Laboratory Biomarker Analysis
    • Scottsdale, Arizona
    • +4 more
    Jan 16, 2023

    Venetoclax Tablets Crushed and Dissolved Into a Solution

    Not yet recruiting
    • Hematologic Malignancy
    • +18 more
    • 1. Drug: The Venetoclax PK study is collecting bodily fluid samples (ie., whole blood and optional cerebrospinal fluid) of patients prescribed venetoclax as crushed tablets per standard of care.
    • Cincinnati, Ohio
      Cincinnati Children's Hospital Medical Center
    Nov 8, 2023

    Relapsed or Refractory CD30+ Malignancies When Re-treated With

    Completed
    • Hodgkin Disease
    • Lymphoma, T-Cell, Cutaneous
    • No Intervention
    • San Bartolome, Alicante, Spain
    • +29 more
    Jul 28, 2022

    Myelodysplastic Syndrome, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Myeloid Leukemia Trial in

    Recruiting
    • Myelodysplastic Syndrome
    • +16 more
    • Computed Tomography
    • +6 more
    • Scottsdale, Arizona
    • +2 more
    Feb 3, 2022